CIK: 0001502287 · Show all filings
Period: Q2 2024 (← Previous) (Next →)
Filing Date: Aug 14, 2024
Total Value ($000): $493,099 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | DUN & BRADSTREET HLDGS INC | 20,742,226 | $192,073 | 39.0% | $20.49 | — | COM | 26484T106 |
| — | WALKME LTD. | 10,366,855 | $144,825 | 29.4% | $29.75 | — | ORD SHS | M97628107 |
| — | MONEYLION, INC. | 622,931 | $45,810 | 9.3% | $12.01 | — | CL A | 60938K304 |
| — | ROCKET LAB USA, INC. | 8,206,916 | $39,393 | 8.0% | $16.13 | — | COM | 773122106 |
| RBLX | ROBLOX CORPORATION | 466,666 | $17,365 | 3.5% | $36.89 | -3.5% | CL A | 771049103 |
| PATH | UIPATH, INC. | 1,286,527 | $16,313 | 3.3% | $60.06 | -71.2% | CL A | 90364P105 |
| — | HILLEVAX, INC. | 826,569 | $11,952 | 2.4% | $11.39 | — | COM | 43157M102 |
| TRDA | ENTRADA THERAPEUTICS, INC. | 761,277 | $10,848 | 2.2% | $16.89 | — | COM | 29384C108 |
| PHAT | PHATHOM PHARMACEUTICALS, INC. | 422,085 | $4,347 | 0.9% | $33.23 | -69.0% | COM | 71722W107 |
| — | DOMA HOLDINGS INC. | 595,180 | $3,613 | 0.7% | $4.94 | — | COM NEW | 25703A203 |
| — | NEUEHEALTH INC. | 525,250 | $2,857 | 0.6% | $12.22 | — | COM NEW | 10920V404 |
| TNYA | TENAYA THERAPEUTICS, INC. | 462,163 | $1,433 | 0.3% | $21.49 | -80.8% | COM | 87990A106 |
| — | VACASA, INC. | 147,261 | $717 | 0.1% | $6.82 | — | CL A NEW | 91854V206 |
| GROV | GROVE COLLABORATIVE HOLDINGS, INC. | 380,383 | $673 | 0.1% | $2.20 | -27.2% | COM CL A | 39957D201 |
| SEMR | SEMRUSH HOLDINGS, INC. | 46,875 | $628 | 0.1% | $13.86 | 0.0% | CL A COM | 81686C104 |
| FINV | FINVOLUTION GROUP | 52,521 | $251 | 0.1% | $4.77 | — | SPONSORED ADS | 31810T101 |